The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Arthur J. Higgins net worth and biography

Arthur Higgins Biography and Net Worth

Director of Ecolab

Operating Advisor to Abu Dhabi Investment Authority (ADIA), a sovereign globally-diversified wealth fund of the Government of the Emirate of Abu Dhabi. Director of Ecolab since 2010. Member of the Compensation and Safety, Health and Environment Committees.

Prior to joining ADIA, Mr. Higgins served as Consultant to Blackstone Healthcare Partners of The Blackstone Group from June 2010 until June 2021. He also served as non-executive chairman of the board of Assertio Holdings, Inc., successor issuer to Assertio Therapeutics, Inc., from May 2020 until December 2020. Prior to that, he served as President, Chief Executive Officer and a member of the board of directors of Assertio Therapeutics, Inc. from March 2017 until its merger with Zyla Life Sciences in May 2020. Previously, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010. Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001. He is past member of the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PHRMA), Council member of the International Federation of Pharmaceutical Manufacturers (IFPMA) and President of the European Federation of Pharmaceutical Industries Association (EFPIA). He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

Qualifications – Mr. Higgins has extensive leadership experience in the global healthcare market. Through leadership positions with large healthcare developers and manufacturers in both the United States and Europe, Mr. Higgins has gained deep knowledge of the healthcare market and the strategies for developing and marketing products in this highly regulated area. This knowledge and industry background allows him to provide valuable insight to Ecolab’s growing Healthcare business, which is developing in both the U.S. and Europe. In addition, his global perspective from years of operating global businesses and his background in working with high growth companies fits well with Ecolab’s ambitions for global growth and provide him experiences from which to draw to advise Ecolab on strategies for sustainable growth. In his role as Chief Executive Officer of Bayer HealthCare, he gained significant exposure to enterprise risk management as well as quality and operating risk management necessary in a highly regulated industry such as healthcare.

What is Arthur J. Higgins' net worth?: The estimated net worth of Arthur J. Higgins is at least $751,808.00 as of August 23rd, 2023. Mr. Higgins owns 3,400 shares of Ecolab stock worth more than $751,808 as of April 26th. This net worth evaluation does not reflect any other investments that Mr. Higgins may own. Learn More about Arthur J. Higgins' net worth.
How do I contact Arthur J. Higgins?: The corporate mailing address for Mr. Higgins and other Ecolab executives is 1 ECOLAB PLACE, SAINT PAUL MN, 55102. Ecolab can also be reached via phone at (800) 232-6522 and via email at [email protected]. Learn More on Arthur J. Higgins' contact information.
Has Arthur J. Higgins been buying or selling shares of Ecolab?: Arthur J. Higgins has not been actively trading shares of Ecolab during the last ninety days. Most recently, Arthur J. Higgins sold 2,400 shares of the business's stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $181.33, for a transaction totalling $435,192.00. Following the completion of the sale, the director now directly owns 23,975 shares of the company's stock, valued at $4,347,386.75. Learn More on Arthur J. Higgins' trading history.
Who are Ecolab's active insiders?: Ecolab's insider roster includes Nicholas Alfano (EVP), Douglas Baker, Jr. (Chairman), Barbara Beck (Director), Christophe Beck (EVP), Larry Berger (EVP), Darrell Brown (EVP), Angela Busch (EVP), Jerome Charton (EVP), Machiel Duijser (EVP), Jeffrey Ettinger (Director), Arthur Higgins (Director), Scott Kirkland (SVP), David Maclennan (Director), Laurie Marsh (EVP), Michael McCormick (EVP), Tracy McKibben (Director), Timothy Mulhere (EVP), Gail Peterson (SVP), Victoria Reich (Director), Daniel Schmechel (CFO), Elizabeth Simermeyer (EVP), and Jill Wyant (EVP). Learn More on Ecolab's active insiders.
Are insiders buying or selling shares of Ecolab?: During the last year, Ecolab insiders bought shares 2 times. They purchased a total of 1,450 shares worth more than $272,648.50. During the last year, insiders at the basic materials company sold shares 9 times. They sold a total of 84,967 shares worth more than $15,284,403.33. The most recent insider tranaction occured on December, 4th when EVP Laurie M Marsh sold 11,917 shares worth more than $2,281,032.97. Insiders at Ecolab own 0.0% of the company. Learn More about insider trades at Ecolab.
Information on this page was last updated on 12/4/2023.

Arthur J. Higgins Insider Trading History at Ecolab

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/13/2023	Sell	2,400	$181.33	$435,192.00	23,975
8/1/2022	Sell	3,200	$166.74	$533,568.00	22,530
6/1/2020	Sell	3,800	$212.28	$806,664.00	23,304
8/27/2018	Sell	8,700	$149.76	$1,302,912.00	21,363

Arthur J. Higgins Buying and Selling Activity at Ecolab

Ecolab Company Overview

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through three segments: Global Industrial; Global Institutional & Specialty; and Global Healthcare & Life Sciences. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. The Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. In addition, the company provides pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments including education, life sciences, and healthcare customers. Further, it offers colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Today's Range

Now: $221.12

$218.25

$221.86

50 Day Range

MA: $223.78

$215.38

$231.80

2 Week Range

Now: $221.12

$156.72

$231.86

Volume

548,427 shs

Average Volume

1,196,701 shs

Market Capitalization

$63.22 billion

P/E Ratio

46.16

Dividend Yield

1.03%

Beta

1.1